Webinar: COVID-19 and the brain
Join us and GeneTex as Dr. Song discusses his work revealing the ability of SARS-CoV-2 to directly infect the mammalian brain.
Online
After recovering from a COVID-19 infection, some people still experience neurological symptoms - this despite the CNS traditionally being considered immune-privileged.
In this webinar, Dr. Song discussed his work revealing the ability of SARS-CoV-2 to directly infect the mammalian brain (Song et al., J. Exp. Med. 2021).
This important study entailed the use of several elegant approaches to demonstrate SARS-CoV-2 infection of both mouse and human brains, with clear implications for the subset of COVID-19 patients experiencing persistent neurological and neuropsychiatric symptoms after resolution of the acute disease. Dr. Song will also provide updates on his current efforts and offer perspectives on future directions of SARS-CoV-2/COVID-19 research.
Host: GeneTex
When: 4th May 2021 at 17:30 CEST
Where: Online
Registration: Unfortunately, this event is over. But you can watch a recording of it.
Among the antibodies used in the Song et al. 2021 study were two of GeneTex’s SARS-CoV-2 antibodies (GTX635679 and GTX632604), as well as GeneTex’s widely published HIF-1alpha antibody (GTX127309).
Are you interested in GeneTex antibodies? We have a current promotion:
- 10ul for 10 CHF 2021 (incl. GTX127309) Visit promo page
Related images
